The Rate of Apparent Diffusion Coefficient Change With Diffusion Time on Breast Diffusion-Weighted Imaging Depends on Breast Tumor Types and Molecular Prognostic Biomarker Expression.
Journal
Investigative radiology
ISSN: 1536-0210
Titre abrégé: Invest Radiol
Pays: United States
ID NLM: 0045377
Informations de publication
Date de publication:
01 08 2021
01 08 2021
Historique:
pubmed:
5
3
2021
medline:
16
10
2021
entrez:
4
3
2021
Statut:
ppublish
Résumé
The aim of this study was to investigate the variation of apparent diffusion coefficient (ADC) values with diffusion time according to breast tumor type and prognostic biomarkers expression. A total of 201 patients with known or suspected breast tumors were prospectively enrolled in this study, and 132 breast tumors (86 malignant and 46 benign) were analyzed. Diffusion-weighted imaging scans with 2 diffusion times were acquired on a clinical 3-T magnetic resonance imaging scanner using oscillating and pulsed diffusion-encoding gradients (effective diffusion times, 4.7 and 96.6 milliseconds) and b values of 0 and 700 s/mm2. Diagnostic performances to differentiate malignant and benign breast tumors for ADC values at short and long diffusion times (ADCshort and ADClong), ΔADC (the rate of change in ADC values with diffusion time), ADC0-1000 (ADC value from a standard protocol), and standard reading including dynamic contrast-enhanced magnetic resonance imaging (BI-RADS) were investigated. The correlations of ADCshort, ADClong, and ΔADC values with hormone receptor expression and breast cancer subtypes were also analyzed. The ADC values were lower, and ΔADC was higher in malignant tumors compared with benign tumors. The specificity of ADC values at all diffusion times and ΔADC values for differentiating malignant and benign breast tumors was superior to that of BI-RADS (87.0%-95.7% vs 73.9%), whereas the sensitivity was inferior (87.2%-90.7% vs 100%). Lower ADCshort and ADC0-1000 in ER-positive compared with ER-negative cancers (false discovery rate [FDR]-adjusted P = 0.037 and 0.018, respectively) and lower ADCshort, ADClong, and ADC0-1000 in progesterone receptor-positive compared with progesterone receptor-negative cancers (FDR-adjusted P = 0.037, 0.036, and 0.018, respectively) were found. Ki-67-positive cancers had larger ΔADCs than Ki-67-negative cancers (FDR-adjusted P = 0.018). The ADC values vary with different diffusion time and vary in correlation with molecular biomarkers, especially Ki-67. Those results suggest that the diffusion time, which should be reported, might be a useful parameter to consider for breast cancer management.
Identifiants
pubmed: 33660629
doi: 10.1097/RLI.0000000000000766
pii: 00004424-202108000-00005
doi:
Substances chimiques
Biomarkers
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
501-508Informations de copyright
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.
Déclaration de conflit d'intérêts
Conflicts of interest and sources of funding: none declared.
Références
Pinker K, Helbich TH, Morris EA. The potential of multiparametric MRI of the breast. Br J Radiol . 2017;90:20160715.
Iima M, Honda M, Sigmund EE, et al. Diffusion MRI of the breast: current status and future directions. J Magn Reson Imaging . 2020;52:70–90.
Rahbar H, Zhang Z, Chenevert TL, et al. Utility of diffusion-weighted imaging to decrease unnecessary biopsies prompted by breast MRI: a trial of the ECOG-ACRIN cancer research group (A6702). Clin Cancer Res . 2019;25:1756–1765.
Spick C, Pinker-Domenig K, Rudas M, et al. MRI-only lesions: application of diffusion-weighted imaging obviates unnecessary MR-guided breast biopsies. Eur Radiol . 2014;24:1204–1210.
Chang R-F, Chen H-H, Chang Y-C, et al. Quantification of breast tumor heterogeneity for ER status, HER2 status, and TN molecular subtype evaluation on DCE-MRI. Magn Reson Imaging . 2016;34:809–819.
Kim JY, Kim SH, Kim YJ, et al. Enhancement parameters on dynamic contrast enhanced breast MRI: do they correlate with prognostic factors and subtypes of breast cancers? Magn Reson Imaging . 2015;33:72–80.
Sutton EJ, Dashevsky BZ, Oh JH, et al. Breast cancer molecular subtype classifier that incorporates MRI features. J Magn Reson Imaging . 2016;44:122–129.
Fan M, Li H, Wang S, et al. Radiomic analysis reveals DCE-MRI features for prediction of molecular subtypes of breast cancer. PLoS One . 2017;12:e0171683.
Suo S, Cheng F, Cao M, et al. Multiparametric diffusion-weighted imaging in breast lesions: association with pathologic diagnosis and prognostic factors. J Magn Reson Imaging . 2017;46:740–750.
Suo S, Zhang D, Cheng F, et al. Added value of mean and entropy of apparent diffusion coefficient values for evaluating histologic phenotypes of invasive ductal breast cancer with MR imaging. Eur Radiol . 2019;29:1425–1434.
Horvat JV, Bernard-Davila B, Helbich TH, et al. Diffusion-weighted imaging (DWI) with apparent diffusion coefficient (ADC) mapping as a quantitative imaging biomarker for prediction of immunohistochemical receptor status, proliferation rate, and molecular subtypes of breast cancer. J Magn Reson Imaging . 2019;50:836–846.
Goto M, Le Bihan D, Yoshida M, et al. Adding a model-free diffusion MRI marker to BI-RADS assessment improves specificity for diagnosing breast lesions. Radiology . 2019;292:84–93.
Surov A, Clauser P, Chang Y-W, et al. Can diffusion-weighted imaging predict tumor grade and expression of Ki-67 in breast cancer? A multicenter analysis. Breast Cancer Res . 2018;20:58.
Liang J, Zeng S, Li Z, et al. Intravoxel incoherent motion diffusion-weighted imaging for quantitative differentiation of breast tumors: a meta-analysis. Front Oncol . 2020;10:585486.
Baltzer P, Mann RM, Iima M, et al. Diffusion-weighted imaging of the breast—a consensus and mission statement from the EUSOBI international breast diffusion-weighted imaging working group. Eur Radiol . 2020;30:1436–1450.
Iima M, Partridge SC, Le Bihan D. Six DWI questions you always wanted to know but were afraid to ask: clinical relevance for breast diffusion MRI. Eur Radiol . 2020;30:2561–2570.
Le Bihan D, Breton E, Lallemand D, et al. MR imaging of intravoxel incoherent motions: application to diffusion and perfusion in neurologic disorders. Radiology . 1986;161:401–407.
Portnoy S, Flint JJ, Blackband SJ, et al. Oscillating and pulsed gradient diffusion magnetic resonance microscopy over an extended b-value range: implications for the characterization of tissue microstructure. Magn Reson Med . 2013;69:1131–1145.
Xu J, Li K, Smith RA, et al. Characterizing tumor response to chemotherapy at various length scales using temporal diffusion spectroscopy. PLoS One . 2012;7:e41714.
Iima M, Yamamoto A, Kataoka M, et al. Time-dependent diffusion MRI to distinguish malignant from benign head and neck tumors. J Magn Reson Imaging . 2019;50:88–95.
Teruel JR, Cho GY, Moccaldi Rt M, et al. Stimulated echo diffusion tensor imaging (STEAM-DTI) with varying diffusion times as a probe of breast tissue. J Magn Reson Imaging . 2017;45:84–93.
Iima M, Nobashi T, Imai H, et al. Effects of diffusion time on non-Gaussian diffusion and intravoxel incoherent motion (IVIM) MRI parameters in breast cancer and hepatocellular carcinoma xenograft models. Acta Radiol Open . 2018;7:2058460117751565.
Maekawa T, Hori M, Murata K, et al. Choroid plexus cysts analyzed using diffusion-weighted imaging with short diffusion-time. Magn Reson Imaging . 2019;57:323–327.
Wagner F, Laun FB, Kuder TA, et al. Temperature and concentration calibration of aqueous polyvinylpyrrolidone (PVP) solutions for isotropic diffusion MRI phantoms. PLoS One . 2017;12:e0179276.
Eby PR, DeMartini WB, Gutierrez RL, et al. Characteristics of probably benign breast MRI lesions. AJR Am J Roentgenol . 2009;193:861–867.
Tavassoli FA, Devilee P, eds. World Health Organization classification of tumours: pathology and genetics of tumours of the breast and female genital organs . Lyon, France: IARC Press, 2003.
Goldhirsch A, Wood WC, Coates AS, et al. Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen international expert consensus on the primary therapy of early breast cancer 2011. Ann Oncol . 2011;22:1736–1747.
Iima M, Kataoka M, Kanao S, et al. Intravoxel incoherent motion and quantitative non-Gaussian Diffusion MR imaging: evaluation of the diagnostic and prognostic value of several markers of malignant and benign breast lesions. Radiology . 2018;287:432–441.
Pepe MS. The Statistical Evaluation of Medical Tests for Classification and Prediction . Oxford, United Kingdom: Oxford University Press; 2003.
Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc B Methodol . 1995;57:289–300.
Reynaud O. Time-dependent diffusion MRI in cancer: tissue modeling and applications. Front Phys . 2017;5.
Lemberskiy G, Rosenkrantz AB, Veraart J, et al. Time-dependent diffusion in prostate cancer. Invest Radiol . 2017;52:405–411.
Springer CS Jr. Using 1H2O MR to measure and map sodium pump activity in vivo. J Magn Reson . 2018;291:110–126.
Dietzel M, Krug B, Clauser P, et al. A multicentric comparison of apparent diffusion coefficient mapping and the Kaiser score in the assessment of breast lesions. Invest Radiol . 2020.
Pinker K, Bickel H, Helbich TH, et al. Combined contrast-enhanced magnetic resonance and diffusion-weighted imaging reading adapted to the "breast imaging reporting and data system" for multiparametric 3-T imaging of breast lesions. Eur Radiol . 2013;23:1791–1802.
Brooks MD, Burness ML, Wicha MS. Therapeutic implications of cellular heterogeneity and plasticity in breast Cancer. Cell Stem Cell . 2015;17:260–271.
Rye IH, Trinh A, Saetersdal AB, et al. Intratumor heterogeneity defines treatment-resistant HER2+ breast tumors. Mol Oncol . 2018;12:1838–1855.
Park SH, Choi HY, Hahn SY. Correlations between apparent diffusion coefficient values of invasive ductal carcinoma and pathologic factors on diffusion-weighted MRI at 3.0 tesla. J Magn Reson Imaging . 2015;41:175–182.
Cho GY, Moy L, Kim SG, et al. Evaluation of breast cancer using intravoxel incoherent motion (IVIM) histogram analysis: comparison with malignant status, histological subtype, and molecular prognostic factors. Eur Radiol . 2016;26:2547–2558.
Inwald EC, Klinkhammer-Schalke M, Hofstädter F, et al. Ki-67 is a prognostic parameter in breast cancer patients: results of a large population-based cohort of a cancer registry. Breast Cancer Res Treat . 2013;139:539–552.
Lee SH, Shin HJ, Moon WK. Diffusion-weighted magnetic resonance imaging of the breast: standardization of image acquisition and interpretation. Korean J Radiol . 2021;22:9–22.